High-sensitivity C-reactive Protein and United Kingdom Prospective Diabetes Study (UKPDS) Risk Score in Type 2 Diabetes

Korea University56 enrolled

Overview

The UKPDS risk score is recommended to assess global risk for future coronary heart disease (CHD) events in primary prevention. Recently, high-sensitivity C-reactive protein (hsCRP) has emerged as a strong independent risk factor for CHD. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a promising imaging technique for the evaluation of vascular inflammation that reflects vulnerable atherosclerotic plaque.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Atherosclerosis Type 2 Diabetes

Eligibility

Sex: ALLMin age: 16 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Type 2 diabetes Exclusion Criteria: * Myocardial infarction, unstable angina, stroke, peripheral artery disease, or cardiovascular revascularization * Resting blood pressure ≥160/100 mmHg * Malignancy, or severe renal or hepatic disease * Participants were free of any lipid-lowering therapies and postmenopausal hormone replacement therapy at least the 6 month period prior to enrollment * History of inflammatory condition or those taking medications that might affect inflammatory status within 6 months

Locations (1)

Korea University Guro Hospital Dept. of Endocrinology

Seoul, South Korea

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.